Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Federal Trade Commission
Teva
Daiichi Sankyo
Chinese Patent Office
Baxter

Generated: August 17, 2019

DrugPatentWatch Database Preview

Litigation Details for Teva Pharmaceuticals USA Inc. v. Synthon Pharmaceuticals, Inc. (D. Del. 2014)

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Teva Pharmaceuticals USA Inc. v. Synthon Pharmaceuticals, Inc. (D. Del. 2014)

Docket   Try a Free Trial Date Filed 2014-11-18
Court District Court, D. Delaware Date Terminated
Cause 35:271 Patent Infringement Assigned To Gregory Moneta Sleet
Jury Demand None Referred To
Parties PFIZER INC.; SYNTHON B.V.; SYNTHON PHARMACEUTICALS INC.; SYNTHON PHARMACEUTICALS, INC.; SYNTHON S.R.O. BLANSKO; TEVA NEUROSCIENCE INC; TEVA PHARMACEUTICAL INDUSTRIES LTD; TEVA PHARMACEUTICALS USA INC.; YEDA RESEARCH AND DEVELOPMENT CO LTD.
Patents 8,232,250; 8,399,413
Attorneys Brian J. Prew; Daryl L. Wiesen; David M. Hashmall; Elizabeth J. Holland; John T. Bennett; John W. Shaw; Karen Elizabeth Keller; Melanie K. Sharp; Nicholas K. Mitrokostas; William G. James
Link to Docket External link to docket
Small Molecule Drugs cited in Teva Pharmaceuticals USA Inc. v. Synthon Pharmaceuticals, Inc.
The small molecule drug covered by the patents cited in this case is   Try a Free Trial .

Details for Teva Pharmaceuticals USA Inc. v. Synthon Pharmaceuticals, Inc. (D. Del. 2014)

Date Filed Document No. Description Snippet Link To Document
2014-11-18 1 Complaint of United States Patent No. 8,232,250 (“the ’250 patent”) and United States Patent No. 8,399,413 (“the…206873. COUNT I FOR INFRINGEMENT OF U.S. PATENT NO. 8,232,250 BY DEFENDANTS 71. The allegations…JUDGMENT OF INFRINGMENT OF U.S. PATENT NO. 8,232,250 BY DEFENDANTS 86. The allegations… the ’250 patent is attached as Exhibit A. The ’413 Patent 55. The ’413 patent, entitled… BACKGROUND The ’250 Patent 49. The ’250 patent, entitled “Low Frequency Glatiramer External link to document
2014-11-18 4 Patent/Trademark Report to Commissioner the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 8,232,250 B2; US 8,399,413 …18 November 2014 1:14-cv-01419 830 Patent None District Court, D. Delaware External link to document
Date Filed Document No. Description Snippet Link To Document

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
McKesson
Medtronic
Colorcon
Moodys
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.